p21-Dependent Protective Effects of a Carbon Monoxide–Releasing Molecule-3 in Pulmonary Hypertension
Author(s) -
Shariq Abid,
Amal Houssaïni,
Nathalie Mouraret,
Élisabeth Marcos,
Valérie Amsellem,
Feng Wan,
Jean Luc Dubois-Randé,
Geneviève Dérumeaux,
Jorge Boczkowski,
Roberto Motterlini,
Serge Adnot
Publication year - 2013
Publication title -
arteriosclerosis thrombosis and vascular biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.007
H-Index - 270
eISSN - 1524-4636
pISSN - 1079-5642
DOI - 10.1161/atvbaha.113.302302
Subject(s) - hypoxia (environmental) , inhalation , pulmonary hypertension , lung , corm , chemistry , endocrinology , pulmonary artery , medicine , pharmacology , biology , anesthesia , oxygen , organic chemistry , agronomy
Carbon monoxide-releasing molecules (CORMs) represent a pharmacological alternative to CO gas inhalation. Here, we questioned whether CORM-3, a well-characterized water-soluble CORM, could prevent and reverse pulmonary hypertension (PH) in chronically hypoxic mice and in smooth muscle promoter 22 serotonin transporter mice overexpressing the serotonin transporter in smooth muscle cells (SMCs).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom